Business · 23/06/1994Updated: 10/16/2026 · 1 min read
Clay-Park Labs, Inc.; Withdrawal of Approval of Three Abbreviated Applications
The Food and Drug Administration (FDA) is withdrawing approval of three applications held by Clay-Park Labs, Inc. due to concerns over the reliability of submitted data and information.
Original source language: Federal Register — Health and Human ServicesOpen original release →